![Richard Brudnick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Brudnick
Direttore/Membro del Consiglio presso
INFLARX N.V.
Patrimonio netto: 1 M $ in data 30/09/2026
Profilo
Richard H.
Brudnick is currently an Independent Non-Executive Director at InflaRx NV since 2019, an Independent Director at Scholar Rock Holding Corp.
since 2023, an Independent Director at Volition America, Inc. since 2021, and a Venture Advisor at Israel Biotech Fund since 2018.
Formerly, Mr. Brudnick was President & Chief Executive Officer at James Brudnick Co., Inc. from 1984 to 1998, Independent Director at VolitionRX Ltd. from 2021 to 2023, Director at Tamarix Pharma Ltd, Senior VP-Corporate Development & Strategy at Biogen, Inc. from 2014 to 2016, Chief Business Officer & Head-Strategy at Codiak BioSciences, Inc. from 2018 to 2022, Executive Vice President-Business Development at Bioverativ, Inc. from 2016 to 2018, and Chief Business Officer at Prime Medicine, Inc. Education includes an undergraduate degree from Massachusetts Institute of Technology in 1978, an MBA from MIT Sloan School of Management in 1980, and additional undergraduate and graduate studies at MIT Sloan School of Management.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 04/06/2026 | 21.896 ( 0,02% ) | 1 M $ | 30/09/2026 | |
INFLARX N.V. 0,03% | 18/03/2026 | 50.000 ( 0,03% ) | 90 000 $ | 30/09/2026 |
PRIME MEDICINE, INC. 0,01% | 20/05/2025 | 20.000 ( 0,01% ) | 61 100 $ | 30/09/2026 |
Posizioni attive di Richard Brudnick
| Società | Posizione | Inizio |
|---|---|---|
| INFLARX N.V. | Direttore/Membro del Consiglio | 14/02/2019 |
| SCHOLAR ROCK HOLDING CORPORATION | Direttore/Membro del Consiglio | 06/04/2023 |
Volition America, Inc.
 Volition America, Inc. Medical/Nursing ServicesHealth Services Provides cancer diagnostic services | Direttore/Membro del Consiglio | 25/03/2021 |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Consulente / Consigliere | 01/01/2018 |
Precedenti posizioni note di Richard Brudnick
| Società | Posizione | Fine |
|---|---|---|
| VOLITIONRX LIMITED | Direttore/Membro del Consiglio | 23/06/2023 |
| CODIAK BIOSCIENCES | Corporate Officer/Principal | 01/07/2022 |
| BIOVERATIV INC | Corporate Officer/Principal | 01/03/2018 |
| BIOGEN INC. | Corporate Officer/Principal | 01/05/2016 |
James Brudnick Co., Inc. | Amministratore Delegato | 02/01/1998 |
Formazione di Richard Brudnick
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
90
Relazioni di 1° grado
13
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 13 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
James Brudnick Co., Inc. | |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
VolitionRX Ltd.
 VolitionRX Ltd. Medical SpecialtiesHealth Technology Develops blood tests to help diagnose a range of cancers and other diseases | Health Technology |
MIT Sloan School of Management
 MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Finance |
Codiak BioSciences, Inc.
 Codiak BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops exosome based therapeutics | Health Technology |
Bioverativ, Inc.
 Bioverativ, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in discovery, research, development and commercialization of therapies for hemophilia & blood disorders | Health Technology |
InflaRx NV
 InflaRx NV BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Scholar Rock Holding Corp.
 Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | Health Technology |
Volition America, Inc.
Volition America, Inc. Medical/Nursing ServicesHealth Services Provides cancer diagnostic services | Health Services |
Prime Medicine, Inc.
 Prime Medicine, Inc. BiotechnologyHealth Technology Develops CRISPR gene editing technology | Health Technology |
Tamarix Pharma Ltd
 Tamarix Pharma Ltd Pharmaceuticals: MajorHealth Technology Develops a novel small compounds for reducing excessive apoptosis | Health Technology |
